公开(公告)号：US07048941B2

公开(公告)日：2006-05-23

申请号：US10107664

申请日：2002-03-26

Applicant: Paul Altaffer ,  Alexander R. Conn ,  Joshua A. Duberman ,  David Lytle ,  Kerry Hughes

Inventor： Paul Altaffer ,  Alexander R. Conn ,  Joshua A. Duberman ,  David Lytle ,  Kerry Hughes

IPC: A61K47/00 ,  A61K35/78

CPC classification number: A23G1/48 ,  A23G1/325 ,  A23G1/426 ,  A23G3/34 ,  A23L33/10 ,  A23L33/105 ,  A23L33/175 ,  A23L33/30 ,  A61K9/0056

Abstract: A novel chocolate product for use in delivering medicaments and/or nutrients to animals, particularly humans, specially formulated so that the craving for such product by animals, particularly humans, is significantly greater than the craving for chocolate conventionally used in pharmaceutical compositions and the concentration, optimization, and the addition of endogenous and exogenous ingredients to increase such craving as well as to treat specific indications. The chocolate product contains: from about 0.5 to about 200 milligrams, more preferably from about 5 to about 20 milligrams, of one or more biogenic amines per 1 gram of the chocolate product; from about 10 to about 500 milligrams, more preferably form about 20 to about 200 milligrams, of one or more amino acids per 1 gram of the chocolate product; (C) from about 1 microgram to about 20 milligrams, more preferably from about 10 micrograms to about 10 milligrams, of one or more of: methyl tetrahydroisoquinoline, N-acylethanolamines, and/or anandamide and/or salsolinol per 1 gram of the chocolate product; (D) from about 0.2 to about 30 milligrams of at least one trace mineral per 1 gram of the chocolate product; and (E) from 0.6 to about 500 milligrams, more preferably from about 35 to about 100 milligrams, of one or more methylxanthine alkaloids per 1 gram of the chocolate product. The chocolate product used in this invention also preferably contains effective amounts of at least one chocolate aroma and at least one vanilla aroma.

Abstract translation: 用于向动物，特别是人类递送药物和/或营养物质的新颖的巧克力产品，特别配制成使得动物，特别是人类对这种产品的渴望明显大于药物组合物中常规使用的巧克力的渴望，并且浓度 ，优化和添加内源和外源成分以增加这种渴望以及治疗特定适应症。 所述巧克力产品包含：每1克巧克力产品约0.5至约200毫克，更优选约5至约20毫克的一种或多种生物胺; 约10至约500毫克，更优选形成约20至约200毫克的每1g巧克力产品中的一种或多种氨基酸; （C）每1g巧克力约1微克至约20毫克，更优选约10微克至约10毫克的一种或多种以下的一种或多种：甲基四氢异喹啉，N-酰基乙醇胺和/或一种和酰胺和/或沙林多酚 产品; （D）每1克巧克力产品约0.2至约30毫克的至少一种痕量矿物; 和（E）每1克巧克力产品0.6至约500毫克，更优选约35至约100毫克的一种或多种甲基黄嘌呤生物碱。 用于本发明的巧克力产品还优选含有有效量的至少一种巧克力香气和至少一种香草香气。

公开(公告)号：US20060283989A1

公开(公告)日：2006-12-21

申请号：US11156387

申请日：2005-06-20

Applicant: David Lytle

Inventor： David Lytle

IPC: B05B5/025 ,  F23D11/32 ,  B05B5/00

CPC classification number: B05D5/12 ,  B05D1/32 ,  B05D1/42 ,  C09D5/38 ,  E04F13/02 ,  E04F21/04 ,  H01F1/0027 ,  H01F41/16

Abstract: A method of applying a magnetic coating to a surface including steps of releasably attaching a framing member to a surface, the framing member defining at least one opening; applying a magnetic coating to the surface within said opening; allowing the magnetic coating to dry; and removing the framing member from the surface, such that the magnetic coating remains fixed to the surface. The framing member is removed from the surface, and additional magnetic coating is applied to the surface to fill in gaps left from removing the framing member.

Abstract translation: 一种将磁性涂层施加到包括将框架构件可释放地附接到表面的步骤的表面的方法，所述框架构件限定至少一个开口; 在所述开口内的表面上施加磁性涂层; 使磁性涂层干燥; 以及从所述表面移除所述框架构件，使得所述磁性涂层保持固定在所述表面上。 将框架构件从表面移除，并且附加的磁性涂层施加到表面以填充从移除框架构件留下的间隙。

公开(公告)号：US20060134181A1

公开(公告)日：2006-06-22

申请号：US11351781

申请日：2006-02-09

Applicant: Paul Altaffer ,  Alexander Conn ,  Joshua Duberman ,  David Lytle ,  Kerry Hughes

Inventor： Paul Altaffer ,  Alexander Conn ,  Joshua Duberman ,  David Lytle ,  Kerry Hughes

IPC: A61K9/68 ,  A23G3/00 ,  A61K36/898

Abstract: A novel chocolate product for use in delivering medicaments and/or nutrients to animals, particularly humans, specially formulated so that the craving for such product by animals, particularly humans, is significantly greater than the craving for chocolate conventionally used in pharmaceutical compositions and the concentration, optimization, and the addition of endogenous and exogenous ingredients to increase such craving as well as to treat specific indications. The chocolate product contains: from about 0.5 to about 200 milligrams, more preferably from about 5 to about 20 milligrams, of one or more biogenic amines per 1 gram of the chocolate product; from about 10 to about 500 milligrams, more preferably form about 20 to about 200 milligrams, of one or more amino acids per 1 gram of the chocolate product; (C) from about 1 microgram to about 20 milligrams, more preferably from about 10 micrograms to about 10 milligrams, of one or more of: methyl tetrahydroisoquinoline, N-acylethanolamines, and/or anandamide and/or salsolinol per 1 gram of the chocolate product; (D) from about 0.2 to about 30 milligrams of at least one trace mineral per 1 gram of the chocolate product; and (E) from 0.6 to about 500 milligrams, more preferably from about 35 to about 100 milligrams, of one or more methylxanthine alkaloids per 1 gram of the chocolate product. The chocolate product used in this invention also preferably contains effective amounts of at least one chocolate aroma and at least one vanilla aroma.